Survey Results: Challenges & Solutions to Improve Access to Routine Pediatric Immunisation in Europe
The complete survey findings deck — objectives, methodology, respondent profile and detailed results — from the 2022 study of 106 respondents across Europe on how to better prioritise routine paediatric immunisation.
Key messages
- 94% of healthcare providers and 88% of stakeholder organisations rank encouraging routine paediatric vaccination as a top or mid-level priority.
- Top parent barriers: conflicting information (56%), individual vaccine-safety concerns (51%) and doubts that vaccines are necessary (45%).
- Healthcare professionals are by far the most credible (64%) and influential (58%) voice — no respondent rated vaccine manufacturers as credible.
- The clearest call to action: parent-friendly educational materials (37%) and safety-focused messages delivered via social media.
In October 2022, the Excellence in Pediatrics Institute, with support from Pfizer, surveyed paediatric healthcare providers and civic, advocacy and HCP stakeholder organisations across Europe. The survey received 106 valid responses (fielded 6–21 October 2022).
